Industry Insights

51. Cleanroom Data Analytics For Setting Up Environmental Monitoring 6/24/2025

    Discover how digital integration enhances compliance, streamlines operations, and enables proactive planning for contamination control in pharmaceutical manufacturing

52. How Strategically Partnering With Academia Supports Biotech R&D Goals 9/14/2023

    For early-stage biotechs, partnering with leading academic institutions can help your firm cut costs and boost the returns on R&D investments while making key research and industry connections that can assist in the development, and ultimate commercialization, of your drug/therapy products.

53. Key Benefits Of A "People In Plant" Program For The Pharma Industry 8/3/2023

    Many pharmaceutical companies have embraced the concept of a “People in Plant” program. Explore the significant benefits that arise from implementing a People in Plant program in the pharma industry.

54. COVID-19 Vaccine Manufacturing Challenges Spark Surge In Outsourcing Deals 10/19/2020

    As the pharma industry scrambles to develop one or more viable COVID-19 vaccines, the greatest hurdle to immunizing the world’s population is the manufacture of billions of doses in parallel. In response to this challenge, vaccine developers are signing an unprecedented number of outsourcing agreements with CMOs and other service providers.

55. If Your Data Could Talk... 9/27/2024

    Explore two examples where data contextualization plays a critical role in a biopharma manufacturing environment, and learn how to get your data to speak the same language across different systems.

56. Critical Thinking In Root Cause Investigations: Asking The Right Questions 7/27/2020

    As we write or review a root cause investigation, it is up to each of us to challenge the information we are given, and ensure it stands up to a critical analysis.

57. 2022 Outsourcing Trends In Biopharmaceutical Manufacturing 6/15/2022

    The continued focus on productivity and efficiency is moving manufacturers to increasingly consider outsourcing activities. Biomanufacturers are spending more, demanding better technologies, and expressing greater optimism. This article shares the trends in outsourced activities, percentages of activities outsourced, outsourcing destinations, and offshoring.

58. Bringing CRISPR Into The CAR-T Process 6/10/2024

    CAR-T cell therapy has been limited by high costs and lengthy manufacturing. Novel methods are bringing exciting advancements in CRISPR-based gene editing that hold promise for overcoming hurdles.

59. Cleaning Up The Systems Mess: A Phased Approach To Implementing Real Automation And EBRS 5/20/2020

    The biopharma industry uses the most sophisticated microbiological and genomic technology, and we experience waves of advancements in therapies driven by our computing and communications technology. So, why are we still drowning in 100-page paper batch records, books of SOPs on the plant floor, and paper documents being handled by operators?

60. Maintaining CQA's As Manufacturing Process Scale From 2D to 3D 6/23/2022

    We discuss critical process parameters that may be utilized to control for CQAs in 3D bioreactor systems and the comparability of CQAs and functional attributes between hMSCs manufactured in 2D planar culture vs. 3D bioreactor culture.